|
Bristow, C L; Di Meo, F; Arnold, R R (1998) Specific activity of alpha1proteinase inhibitor and alpha2macroglobulin in human serum: application to insulin-dependent diabetes mellitus. Clin Immunol Immunopathol 89:247-59
|
|
Bristow, C L; Fiscus, S A; Flood, P M et al. (1995) Inhibition of HIV-1 by modification of a host membrane protease. Int Immunol 7:239-49
|
|
Naidu, A S; Arnold, R R (1994) Lactoferrin interaction with salmonellae potentiates antibiotic susceptibility in vitro. Diagn Microbiol Infect Dis 20:69-75
|
|
Ballinger, C A; Mendis-Handagama, C; Kalmar, J R et al. (1994) Changes in the localization of catalase during differentiation of neutrophilic granulocytes. Blood 83:2654-68
|
|
Akin, D T; Lu, M Q; Lu, S J et al. (1994) Bactericidal activity of different forms of lactoferrin. Adv Exp Med Biol 357:61-70
|
|
Kalmar, J R; Arnold, R R (1988) Killing of Actinobacillus actinomycetemcomitans by human lactoferrin. Infect Immun 56:2552-7
|
|
Kalmar, J R; Arnold, R R; Warbington, M L et al. (1988) Superior leukocyte separation with a discontinuous one-step Ficoll-Hypaque gradient for the isolation of human neutrophils. J Immunol Methods 110:275-81
|
|
Rundegren, J L; Arnold, R R (1987) Bacteria-agglutinating characteristics of secretory IgA and a salivary agglutinin. Adv Exp Med Biol 216B:1005-13
|
|
Motley, M A; Arnold, R R (1987) Cofactor requirements for expression of lactoferrin bactericidal activity on enteric bacteria. Adv Exp Med Biol 216A:591-9
|
|
Rundegren, J; Arnold, R R (1987) Differentiation and interaction of secretory immunoglobulin A and a calcium-dependent parotid agglutinin for several bacterial strains. Infect Immun 55:288-92
|
Showing the most recent 10 out of 12 publications
